Other
Net Change in Cash
Biogen Net Change in Cash decreased by 64.6% to $392.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 107.5%, from $189.00M to $392.20M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2017
Last reportedQ1 2026
How to read this metric
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
Detailed definition
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
Peer comparison
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
Metric ID:
net_change_in_cashHistorical Data
16 periods
| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $510.10M | $735.40M | -$502.70M | $958.50M | $1.08B | -$541.10M | -$276.30M | -$301.20M | -$1.29B | $47.60M | $847.10M | $750.20M | $189.00M | $92.20M | $1.11B | $392.20M |
| QoQ Change | — | +44.2% | -168.4% | +290.7% | +12.8% | -150.0% | +48.9% | -9.0% | -326.9% | +103.7% | >999% | -11.4% | -74.8% | -51.2% | >999% | -64.6% |
| YoY Change | — | — | — | +87.9% | — | -7.6% | -128.8% | -127.9% | — | +108.8% | +406.6% | +158.3% | +297.1% | -89.1% | — | +107.5% |
Range-$1.29B – $1.11B
CAGR-6.8%
Avg YoY Growth+81.3%
Median YoY Growth+97.7%
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Biogen's net change in cash?
- Biogen (BIIB) reported net change in cash of $392.20M in Q1 2026.
- How has Biogen's net change in cash changed year-over-year?
- Biogen's net change in cash increased by 107.5% year-over-year, from $189.00M to $392.20M.
- What does net change in cash mean?
- The total change in the company's cash position over the period.